Resmed debt and dilution100

Borrowings, liquidity, share count and stock-based dilution.

Total debt

USD millions

$659.365M

Cash & equivalents

USD millions

$1,469.234M

Net debt

USD millions

$-809.869M

Debt / equity

0.1×

Debt / assets

7.35%

Net debt / EBITDA

× · TTM

-0.39×

Debt / FCF

× · TTM

0.4×

Interest coverage

× · TTM

—

Current ratio

3.1×

Diluted shares

Million shares

145.11M shares

Basic shares

Million shares

144.71M shares

Share count growth

-1.21%

Share repurchases

USD millions

$200M

Quarterly data

Resmed capital history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal period	Ended	Total debtUSD millions	Cash & equivalentsUSD millions	Net debtUSD millions	Debt / equity×	Debt / assets%	Net debt / EBITDA×	Debt / FCF×	Interest coverage×	Current ratio×	Diluted sharesMillion shares	Basic sharesMillion shares	Share count growth%	Share repurchasesUSD millions
FY 2026 Q4	Jun 30, 2026	659.37	1,469.23	-809.87	0.1×	7.35%	-0.39×	0.4×	—	3.1×	145.11	144.71	-1.21%	200
FY 2026 Q3	Mar 31, 2026	664.1	1,660.51	-996.42	0.1×	7.56%	-0.47×	0.38×	—	3.01×	145.72	145.34	-0.94%	175.01
FY 2026 Q2	Dec 31, 2025	663.83	1,417.07	-753.24	0.11×	7.81%	-0.37×	0.37×	—	3.06×	146.37	145.84	-0.66%	175.01
FY 2026 Q1	Sep 30, 2025	668.56	1,383.85	-715.29	0.11×	8.05%	-0.37×	0.38×	—	2.89×	146.9	146.18	-0.46%	150.01
FY 2025 Q4	Jun 30, 2025	668.29	1,209.45	-541.16	0.11×	8.18%	-0.29×	0.4×	—	3.44×	147.06	146.47	-0.3%	100.01
FY 2025 Q3	Mar 31, 2025	673.03	932.71	-259.68	0.12×	8.89%	-0.15×	0.43×	—	3.41×	147.22	146.72	-0.16%	75.03
FY 2025 Q2	Dec 31, 2024	672.77	521.94	150.82	0.13×	9.42%	0.09×	0.48×	—	3.33×	147.48	146.81	-0.22%	74.99
FY 2025 Q1	Sep 30, 2024	677.47	426.36	251.11	0.13×	9.38%	0.16×	0.5×	—	2.92×	147.6	146.86	-0.15%	50.01
FY 2024 Q4	Jun 30, 2024	707.21	238.36	468.85	0.15×	10.29%	0.31×	0.54×	—	2.59×	147.55	146.92	-0.07%	50
FY 2024 Q3	Mar 31, 2024	1,006.95	237.91	769.04	0.22×	14.78%	0.55×	0.92×	—	3.04×	147.45	146.96	0.03%	50
FY 2024 Q2	Dec 31, 2023	1,226.67	210.25	1,016.42	0.27×	17.76%	0.77×	1.27×	—	3.11×	147.55	147.13	0.29%	50.01
FY 2024 Q1	Sep 30, 2023	1,361.42	209.1	1,152.32	0.32×	20.2%	0.87×	1.67×	—	2.99×	147.49	147.08	0.44%	0
FY 2023 Q4	Jun 30, 2023	1,441.14	227.89	1,213.25	0.35×	21.34%	0.94×	2.51×	—	3.12×	147.62	147.02	0.45%	0
FY 2023 Q3	Mar 31, 2023	1,585.86	227.89	1,357.97	0.4×	23.62%	1.07×	3.76×	—	3.07×	147.4	146.91	0.46%	0
FY 2023 Q2	Dec 31, 2022	1,800.59	253.2	1,547.39	0.48×	26.97%	1.29×	7.61×	—	3.17×	147.41	146.7	0.49%	—
FY 2023 Q1	Sep 30, 2022	795.34	207.16	588.18	0.23×	15.36%	0.5×	2.45×	—	2.94×	147.13	146.43	0.52%	—
FY 2022 Q4	Jun 30, 2022	775.24	273.71	501.53	0.23×	15.21%	0.43×	3.58×	—	2.8×	147.07	146.36	0.52%	—
FY 2022 Q3	Mar 31, 2022	680.7	201.77	478.93	0.21×	13.88%	0.42×	1.87×	44.61×	2.55×	146.96	146.24	0.5%	—
FY 2022 Q2	Dec 31, 2021	679.98	194.48	485.5	0.22×	14.36%	0.43×	1.46×	43.3×	2.49×	147.04	145.99	0.51%	—
FY 2022 Q1	Sep 30, 2021	805.67	276.15	529.52	0.27×	17.04%	0.48×	1.96×	42.15×	2.54×	146.86	145.68	0.54%	—
FY 2021 Q4	Jun 30, 2021	655.35	295.28	360.07	0.23×	13.86%	0.34×	1.03×	37.67×	1.73×	146.62	145.6	0.4%	—
FY 2021 Q3	Mar 31, 2021	731.04	230.64	500.4	0.27×	15.94%	0.48×	0.98×	31.8×	1.67×	145.51	145.51	0.6%	—
FY 2021 Q2	Dec 31, 2020	825.72	255.87	569.86	0.29×	18.06%	0.55×	1.05×	27.54×	2.51×	146.42	145.25	0.72%	—
FY 2021 Q1	Sep 30, 2020	1,056.42	421.41	635.01	0.39×	22.86%	0.63×	1.51×	23.61×	2.61×	146.1	144.9	0.82%	—
FY 2020 Q4	Jun 30, 2020	1,176.12	463.16	712.96	0.47×	25.64%	0.74×	1.66×	20.05×	2.53×	146.14	145.02	0.9%	—
FY 2020 Q3	Mar 31, 2020	1,376.84	352.86	1,023.98	0.61×	30.52%	1.18×	2.68×	16.18×	2.66×	145.68	144.64	0.92%	—
FY 2020 Q2	Dec 31, 2019	1,299.49	204.1	1,095.4	0.58×	29.85%	1.36×	3.03×	14.01×	2.6×	145.58	144.21	0.9%	—
FY 2020 Q1	Sep 30, 2019	1,220.2	172.15	1,048.05	0.58×	29.37%	1.37×	2.47×	13.96×	2.11×	145.1	143.72	0.74%	—
FY 2019 Q4	Jun 30, 2019	1,270.85	147.13	1,123.73	0.61×	30.94%	1.54×	3.26×	16.02×	2.06×	144.91	143.73	0.51%	0
FY 2019 Q3	Mar 31, 2019	1,335.7	146.51	1,189.18	0.66×	32.59%	1.6×	3.49×	20.8×	2.38×	144.33	143.32	0.29%	0
FY 2019 Q2	Dec 31, 2018	1,197.48	149.47	1,048.01	0.61×	31.02%	1.47×	3.04×	23.96×	2.44×	144.35	142.92	0.15%	3.45
FY 2019 Q1	Sep 30, 2018	529.61	230.19	299.42	0.28×	17.27%	0.43×	—	23.62×	2.58×	144.03	142.67	0.3%	19.4
FY 2018 Q4	Jun 30, 2018	281.45	188.7	92.75	0.14×	9.19%	0.14×	0.64×	19.11×	2.08×	144.26	142.99	0.95%	25.9
FY 2018 Q3	Mar 31, 2018	810	704.28	105.72	0.39×	22.92%	0.17×	—	18.15×	3.48×	143.99	142.9	0.84%	19.36
FY 2018 Q2	Dec 31, 2017	1,019.13	858.9	160.23	0.5×	28.6%	0.26×	—	17.37×	1.29×	143.86	142.72	0.99%	—
FY 2018 Q1	Sep 30, 2017	—	811.1	—	—	—	—	—	16.06×	4.72×	143.48	142.25	1.04%	—
FY 2017 Q4	Jun 30, 2017	1,078.61	821.94	256.68	0.55×	31.1%	0.48×	3.07×	15.08×	4.57×	142.72	141.64	0.78%	—
FY 2017 Q3	Mar 31, 2017	1,168.35	827.31	341.04	0.63×	34.14%	0.65×	3.14×	—	4.77×	142.72	141.71	1.09%	—
FY 2017 Q2	Dec 31, 2016	1,168.5	788.15	380.36	0.68×	35.17%	0.74×	2.73×	—	2.23×	142.1	141.31	0.99%	—
FY 2017 Q1	Sep 30, 2016	1,173.14	781.66	391.48	0.66×	35.31%	0.75×	2.58×	—	2.38×	142.09	140.79	0.34%	—
FY 2016 Q4	Jun 30, 2016	1,175	731.43	443.57	0.69×	36.05%	0.86×	2.4×	38.28×	2.22×	142.48	140.55	-0.21%	0
FY 2016 Q3	Mar 31, 2016	435.61	718.5	-282.89	0.26×	17.82%	-0.58×	1×	—	4.89×	141.04	140.19	-0.43%	0
FY 2016 Q2	Dec 31, 2015	401.58	658.8	-257.23	0.26×	17.94%	-0.53×	0.99×	—	5.09×	141.15	139.93	-0.09%	44.2
FY 2016 Q1	Sep 30, 2015	500.59	822.05	-321.47	0.34×	22.2%	-0.66×	1.39×	—	5.96×	141.95	140.31	0.13%	57.86
FY 2015 Q4	Jun 30, 2015	300.59	717.25	-416.66	0.19×	13.76%	-0.86×	0.94×	70.83×	5.4×	142.91	140.85	0.2%	57.01
FY 2015 Q3	Mar 31, 2015	460.58	866.33	-405.74	0.3×	20.22%	-0.84×	1.39×	—	6.06×	142.81	140.79	-0.12%	19.24
FY 2015 Q2	Dec 31, 2014	449.66	880.7	-431.03	0.28×	19.33%	-0.9×	1.35×	—	6×	142.2	140.05	-1.51%	37.25
FY 2015 Q1	Sep 30, 2014	375.7	881.69	-505.99	0.23×	16.27%	-1.06×	1.21×	—	6.04×	142.68	140.13	-1.32%	46.8
FY 2014 Q4	Jun 30, 2014	300.79	905.73	-604.94	0.17×	12.74%	-1.26×	0.94×	66.09×	5.77×	143.16	140.57	-1.47%	32.77
FY 2014 Q3	Mar 31, 2014	395.8	938.56	-542.76	0.23×	16.74%	-1.16×	1.2×	—	6.33×	143.38	140.96	-1.63%	75.81
FY 2014 Q2	Dec 31, 2013	435.81	972.68	-536.86	0.27×	18.58%	-1.16×	1.31×	—	6.44×	145.34	142.2	-0.71%	70.77
FY 2014 Q1	Sep 30, 2013	360.81	976.57	-615.77	0.21×	15.45%	-1.37×	1.04×	—	2.55×	145.46	142.01	-0.45%	22.82
FY 2013 Q4	Jun 30, 2013	300.79	876.05	-575.26	0.19×	13.61%	-1.33×	0.89×	55.55×	2.52×	146.2	142.67	-0.08%	70.92
FY 2013 Q3	Mar 31, 2013	340.82	1,012.7	-671.88	0.19×	14.35%	-1.53×	1.08×	—	2.72×	146.64	143.29	-0.51%	67.29
FY 2013 Q2	Dec 31, 2012	300.85	958.28	-657.43	0.17×	12.91%	-1.57×	0.99×	—	6.09×	146.69	143.21	-2.16%	39.96
FY 2013 Q1	Sep 30, 2012	265.84	890.63	-624.79	0.16×	11.84%	-1.57×	0.82×	—	5.73×	146.06	142.65	-5.13%	8.1
FY 2012 Q4	Jun 30, 2012	250.83	809.54	-558.71	0.16×	11.73%	-1.47×	0.75×	61.51×	5.38×	146.36	142.79	-76.63%	91.72
FY 2012 Q3	Mar 31, 2012	235.98	776.07	-540.09	0.15×	11.08%	-1.52×	0.77×	—	5.15×	147.16	144.02	93,879.16%	65.06
FY 2012 Q2	Dec 31, 2011	226.45	723.23	-496.78	0.15×	11.09%	-1.46×	0.76×	—	5.46×	149.52	146.37	-3.97%	114.27
FY 2012 Q1	Sep 30, 2011	134.1	610.06	-475.97	0.09×	6.93%	-1.41×	0.54×	—	5.06×	154.05	150.37	-0.73%	121.7
FY 2011 Q4	Jun 30, 2011	100.16	735.27	-635.1	0.06×	4.84%	-1.88×	0.46×	151.83×	6.19×	630.03	611.1	—	62.45
FY 2011 Q3	Mar 31, 2011	80.24	671.7	-591.47	0.05×	4.09%	—	—	—	6.28×	0.16	0.15	—	59.53
FY 2011 Q2	Dec 31, 2010	—	616.2	—	—	—	—	—	—	4.64×	157.59	152.42	—	18.72
FY 2011 Q1	Sep 30, 2010	—	540	—	—	—	—	—	—	3.73×	156.75	151.47	—	22.64

Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Debt uses reported borrowings, with overlapping concepts treated as alternatives. Cash excludes restricted cash and short-term investments. Dilution compares split-normalized weighted average basic shares year over year. Share buyback spending does not by itself measure shares retired.

Market prices: Yahoo Finance · RMD, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Total debt: Reported borrowing balances. Uses an aggregate including current maturities, or current plus noncurrent debt. Adds separately disclosed short-term borrowings, with commercial paper as a fallback, unless the selected current/aggregate concept already includes them. Finance leases are included when part of the reported debt concept; undisclosed components are not estimated.
Cash & equivalents: Unrestricted reported cash and cash equivalents. Excludes short-term investments and restricted cash.
Net debt: Total debt − cash and equivalents. Negative means net cash.
Debt / equity: Total debt / equity including noncontrolling interests. Nonpositive equity yields unavailable.
Debt / assets: Total debt / total assets × 100.
Net debt / EBITDA: Period-end net debt / (TTM operating income + TTM depreciation and amortization). Negative net debt is retained.
Debt / FCF: Period-end reported debt / positive TTM free cash flow. Reflects the selected reported capex scope and SBC option.
Interest coverage: TTM operating income / positive TTM interest expense. IFRS finance costs can include more than interest.
Current ratio: Current assets / positive current liabilities.
Diluted shares: Reported weighted average diluted shares, normalized for subsequent recorded stock splits. Fourth-quarter counts use a day-weighted annual/nine-month reconstruction where possible.
Basic shares: Reported weighted average basic shares, normalized for subsequent recorded stock splits.
Share count growth: Year-over-year change in split-normalized weighted average basic shares × 100. A dilution proxy; negative means a lower share count.
Share repurchases: Reported cash payments for repurchase of common shares. This is spending, not a buyback yield.